| Dr Michael Paul Frost, MD | |
|
353 Fairmont Blvd, Rapid City, SD 57701-7375 | |
| (605) 755-8222 | |
| (605) 755-4203 |
| Full Name | Dr Michael Paul Frost |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 353 Fairmont Blvd, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033641501 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 12074 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Fall River Hospital - Cah | Hot springs, SD | Hospital |
| Monument Health Custer Hospital | Custer, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rapid City Emergency Services Pa | 7315934171 | 20 |
News Archive
The Cystic Fibrosis Foundation issued the following statement in response to an announcement by Vertex Pharmaceuticals Inc. regarding promising results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco in combination with another potential CF therapy, VX-661.
Rodney Rosalia et al., in a recent medRxiv preprint research paper, study the longitudinal variation of parameters involved with systemic inflammation in critically ill COVID-19 patients upon EBP treatment.
Skanska has secured the assignment to construct the expansion of the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.
› Verified 1 days ago
| Entity Name | Monument Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588185268 PECOS PAC ID: 5991616427 Enrollment ID: O20031111000854 |
News Archive
The Cystic Fibrosis Foundation issued the following statement in response to an announcement by Vertex Pharmaceuticals Inc. regarding promising results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco in combination with another potential CF therapy, VX-661.
Rodney Rosalia et al., in a recent medRxiv preprint research paper, study the longitudinal variation of parameters involved with systemic inflammation in critically ill COVID-19 patients upon EBP treatment.
Skanska has secured the assignment to construct the expansion of the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.
› Verified 1 days ago
| Entity Name | Rapid City Emergency Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621045 PECOS PAC ID: 7315934171 Enrollment ID: O20040426001322 |
News Archive
The Cystic Fibrosis Foundation issued the following statement in response to an announcement by Vertex Pharmaceuticals Inc. regarding promising results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco in combination with another potential CF therapy, VX-661.
Rodney Rosalia et al., in a recent medRxiv preprint research paper, study the longitudinal variation of parameters involved with systemic inflammation in critically ill COVID-19 patients upon EBP treatment.
Skanska has secured the assignment to construct the expansion of the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Paul Frost, MD Po Box 912882, Denver, CO 80291-2882 Ph: (866) 765-0909 | Dr Michael Paul Frost, MD 353 Fairmont Blvd, Rapid City, SD 57701-7375 Ph: (605) 755-8222 |
News Archive
The Cystic Fibrosis Foundation issued the following statement in response to an announcement by Vertex Pharmaceuticals Inc. regarding promising results from a Phase 2 clinical trial of its cystic fibrosis drug Kalydeco in combination with another potential CF therapy, VX-661.
Rodney Rosalia et al., in a recent medRxiv preprint research paper, study the longitudinal variation of parameters involved with systemic inflammation in critically ill COVID-19 patients upon EBP treatment.
Skanska has secured the assignment to construct the expansion of the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware.
W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.
› Verified 1 days ago
Dr. Jeffrey Anderson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5410 Sheridan Lake Rd, Rapid City, SD 57702 Phone: 605-348-4141 Fax: 605-342-7880 | |
Lauren Buyan, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-8222 | |
Daniel P Hofmann, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 353 Fairmont Blvd, Rapid City, SD 57709 Phone: 605-719-1000 | |
Steven M Ross, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-719-8222 Fax: 605-348-1578 | |
Kelly W Manning, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-8222 Fax: 605-719-4203 | |
Anne Fisher, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-8222 Fax: 605-719-4203 |